BioGaia AB (publ) (STO: BIOG.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
109.60
+0.30 (0.27%)
Oct 4, 2024, 5:29 PM CET

BioGaia AB Company Description

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide.

The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula.

The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee’s dairy product.

The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels.

BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.

BioGaia AB (publ)
BioGaia AB logo
Country Sweden
Founded 1990
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 210
CEO Theresa Agnew

Contact Details

Address:
Kungsbroplan 3
Stockholm, 112 27
Phone 46 8 55 52 93 00
Website biogaia.com

Stock Details

Ticker Symbol BIOG.B
Exchange Nasdaq Stockholm
Fiscal Year January - December
Reporting Currency SEK
ISIN Number SE0017769995
SIC Code 2834

Key Executives

Name Position
Theresa P. Agnew Chief Executive Officer and President
Peter Rothschild M.Sc. Econ., MBA Founder and Chairman
Alexander Kotsinas M.Sc. (Eng.). Executive Vice President and Chief Financial Officer
Ludvig Milesson Chief Operating Officer
Gianfranco Grompone Chief Scientific Officer and Vice President of Research and Development
Caroline Mofors Chief Legal Officer
Linda Hagglund Vice President of Marketing
Angelika Kjelldorff Chief Human Resources Officer
Sebastian Heimfors Vice President and Chief Commercial Officer
Jonathan Gromark Sustainability Manager